// App-Quantinova.ai

: CONVERSION FROM CALCINEURIN INHIBITORS TO SIROLIMUS IN ADVANCED STAGES OF CHRONIC ALLOGRAFT NEPHROPATHY: IS IT BENEFICIAL

Researchers

Presenter

  • Ali ghafari moghadam

Principal Investigators

  • N/A

Medical Centers

  • TUMS (Tehran University of Medical Sciences), Islamic Republic of Iran

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Urology

  • Nephrology

  • Autoimmune (AI)

Disease

  • Chronic allograft nephropathy

  • Obstructive uropathy

  • Renal insufficiency

  • Transplant rejection

  • Renal disease

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • cyclosporin A

  • cyclosporin

  • Prednisolone

  • Tacrolimus

  • Rapacan

  • Mycophenolic acid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved